Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
249 Leser
Artikel bewerten:
(1)

Hearing Aids Market worth USD 11.5 billion by 2030, says Global Market Insights Inc.

Finanznachrichten News

Hearing aids industry is anticipated to register over 5.5% CAGR between 2022 and 2030 due to growing prevalence of hearing loss disorders.

SELBYVILLE, Del., Sept. 8, 2022 /PRNewswire/ -- The hearing aids market value is anticipated to cross USD 11.5 billion by 2030, according to a new research report by Global Market Insights Inc.

Hearing Aids Market

Regulatory authorities and federal agencies are implementing favorable programs and policies to expand the screening of hearing loss and foster accessibility to sufficient treatment. This is expected to accelerate the hearing aids industry growth substantially. Early hearing loss identification followed by regular intervention is important to reduce the negative impacts on cognitive, and psychological development, and verbal communication. In consequence, government bodies have introduced screening programs to increase the diagnosis and optimize treatment of individuals suffering from hearing loss, which is anticipated to bolster business expansion.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/5082

Rising adoption of RITE/RIC hearing aids to promote business landscape

Receiver in the ear/Receiver in canal (RITE/RIC) segment held over USD 1.9 billion in 2021. RITE/RIC hearing aids are gaining increasing preference as they are smaller in comparison to the BTE solutions. These devices transmit sounds using receivers that help in providing the sound directly into the eardrums. These hearing aids are ideal for mild to severe hearing loss and offer comfortable listening across multiple scenarios with consistent noise reduction, enabling users to focus precisely on the speech.

Browse key industry insights spread across 208 pages with 197 market data tables & 27 figures & charts from the report, "Hearing Aids Market Analysis By Product (Behind-the-Ear (BTE), Completely-in-the-Canal/ Invisible-in-Canal (CIC/IIC), In-the-Canal (ITC), In-the-Ear (ITE), Receiver in the ear/Receiver in Canal (RITE/RIC)), By Patient (Adult, Pediatric), Industry Analysis Report, Regional Outlook, Covid-19 Impact Analysis, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030" in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/hearing-aids-market

Favorable regulatory initiatives for pediatric patients to bolster market demand

Pediatric segment held a major share in the hearing aids market. The adoption of supportive policies and initiatives that foster hearing screening and mitigate the prevalence of hearing loss in pediatrics will proliferate the market share. Citing an instance, the Government of India has unveiled programs to promote the detection of hearing loss in kids. These programs will encourage the adoption of hearing aids for the pediatric population.

Growing prevalence of hearing impairment in Asia Pacific to increase product penetration

Asia Pacific hearing aids market is expected to depict a CAGR of 7.6% from 2022 to 2030. This is credited to the growing incidence of hearing loss and increased knowledge regarding hearing aid devices. As per the BMC Public Health article, in 2019, around 27 million people were diagnosed with disabling hearing loss, which represents around 33.5% of the overall registered disabled. With the region holding the world's largest population, hearing impairment has become a critical public health issue in the Asia Pacific.

Key players impacting the hearing aids market through product launches

Major players functioning in the industry include WS Audiology, RION Co. Ltd, Eargo, Inc., ZOUNDS Hearing Inc., Elkon Pvt Ltd, AS AUDIO-SERVICE GmbH, Horentek Hearing Diagnostics, GN Store Nord A/S, SeboTek Hearing Systems, Nano Hearing Aids, IN4 Technology Corporation, Audina Hearing Instruments, Demant A/S, EARTECHNIC, Sonova Holding AG, Starkey, and Microson. Key players are launching new products to bolster their portfolio and establish a firm presence in the global market.

Request for customization of this research report @ https://www.gminsights.com/roc/5082

About Global Market Insights

Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

Contact Us:

Aashit Tiwari
Corporate Sales, USA
Global Market Insights Inc.
Phone: +1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

Photo: https://mma.prnewswire.com/media/1894526/Hearing_Aids_Market.jpg
Logo: https://mma.prnewswire.com/media/661916/GMI.jpg

GMI Logo

© 2022 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.